Last reviewed · How we verify
Standard IV administration of vancomycin — Competitive Intelligence Brief
marketed
Small molecule
Live · refreshed every 30 min
Target snapshot
Standard IV administration of vancomycin (Standard IV administration of vancomycin) — The Methodist Hospital Research Institute.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Standard IV administration of vancomycin TARGET | Standard IV administration of vancomycin | The Methodist Hospital Research Institute | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Standard IV administration of vancomycin CI watch — RSS
- Standard IV administration of vancomycin CI watch — Atom
- Standard IV administration of vancomycin CI watch — JSON
- Standard IV administration of vancomycin alone — RSS
Cite this brief
Drug Landscape (2026). Standard IV administration of vancomycin — Competitive Intelligence Brief. https://druglandscape.com/ci/standard-iv-administration-of-vancomycin. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab